TNF and hemolytic-uremic syndrome: Patients with STEC–HUS have higher plasma levels of TNF-α, IL-6, and lower levels of IL-10 compared to normal controls, a process driven in part by increased expression of Toll-like receptor on circulating PMN (37, 38).